Breathing easier with drug-resistant TB solutions

Every year, 10 million people contract tuberculosis (TB), with 1.5million cases leading to death. Despite being a preventable and curable disease, TB is the world’s top infectious killer. Multidrug-resistant TB is especially dangerous, severely limiting the ability to tackle the condition. Innovation in molecular testing can detect multidrug-resistant TB at an early stage for more effective treatment